We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Lunaphore stated that its LabSat is a CE-marked instrument that complies with applicable product health, safety and environmental regulations of the European Union and will be available in
SegWAY provides solutions for minimally invasive orthopedic procedures. The company is known for its S.E.G-WAY release system, which is a minimally invasive single-portal system that offers less scarring
By the Agreement, GTX and Flint Rehab will develop a next generation SmartSoleÒ noninvasive GPS wearable tracker for those who wander, which will include location-based GPS technology, biometric
Dr. Ken Takegami, MD., and his team at Adult and Pediatric Dermatology of Tullahoma, recently completed the treatment of his first patients on the RADiant dual modality radiotherapy
FIVAD is based on the technology developed by Israel-based medical technology company Leviticus Cardio. The device uses Coplanar Energy Transfer (CET) to wirelessly power a heart pump, a
Cognoa stated that the products are the foundation for the company’s precision health platform designed to support early identification and treatment of pediatric behavioral health conditions. The companys
Nu-Med Plus said that the new unit will open new patient markets by offering in-office treatment options for conditions such as high blood pressure, COPD and ARDS. The
FALCO is working in collaboration with Promega microsatellite instability (MSI) chemistry and assay design and obtained the companion diagnostic approval. The MSI-IVD Kit from FALCO, detects MSI-High within
Confluent Medical is able to support the Nitinol component manufacturers that require the highest performance in Nitinol durability, fatigue-resistance, surface finish and tight tolerances. The High-Performance Nitinol Tubing
Jim Corbett, CathWorks CEO, stated, “We are delighted to have such a notable investor leading this round and for the continued full participation of our existing syndicate of